Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. News
  7. All News
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about ASTELLAS PHARMA INC.
10/19ASTELLAS PHARMA : Receives “2021 Award for Excellence in Corporate Disclosure”..
PU
10/13Astellas and Seagen Complete Enrollment in EV-103 Trial Cohort K Combining PADCEV (enfo..
AQ
10/12ASTELLAS PHARMA : and Seagen Complete Enrollment in EV-103 Trial Cohort K Combining PADCEV..
PU
10/12SEAGEN : Astellas Complete Enrollment in Cohort K of Study of Padcev, Keytruda Combination..
MT
10/12ASTELLAS PHARMA : Seagen and Astellas Complete Enrollment in EV-103 Trial Cohort K Combini..
BU
10/11ASTELLAS PHARMA : World's First Use of Environmentally Friendly Biomass-based Plastic for ..
PU
10/05PRESS RELEASE : MIG Fonds leads EUR65 million Series B financing of iOmx Therapeutics
DJ
10/05PRESS RELEASE : iOmx Therapeutics raises EUR 65 million in Series B round
DJ
10/04PRESS RELEASE : MIG sells portfolio company Hemovent to MicroPort
DJ
10/01ASTELLAS PHARMA : Juntendo University and Astellas Establish "Direct Reprogramming Regener..
PU
09/30ASTELLAS PHARMA : Corporate Strategic Plan 2021—dedicated to realization
PU
09/30ASTELLAS PHARMA : announces the publication of New Contents related to its Corporate Strat..
PU
09/29ASTELLAS PHARMA : Recognized Consistently Among Top Companies for Working Parents
AQ
09/29ASTELLAS PHARMA INC. : Ex-dividend day for interim dividend
FA
09/28ASTELLAS PHARMA : Japan's MHLW Approves PADCEV (enfortumab vedotin) for Advanced Urothelia..
AQ
09/27SEAGEN : Urothelial Cancer Drug Padcev Gets Japanese Regulator's Approval
MT
09/27ASTELLAS PHARMA : Japan's MHLW Approves PADCEV (enfortumab vedotin) for Advanced Urothelia..
PU
09/27ASTELLAS PHARMA : Japan's MHLW Approves PADCEV« (enfortumab vedotin) for Advanced Urotheli..
BU
09/23ASTELLAS PHARMA : Tohoku University and Astellas Establish Second Phase of Comprehensive I..
PU
09/23ASTELLAS PHARMA INC. : will present 12-week results (S-13) from the pivotal Phase 3 SKYLIG..
AQ
09/22Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic..
AQ
09/22Astellas to Present Fezolinetant 12-Week Findings from Phase 3 SKYLIGHT 2Ö Trial in Ora..
CI
09/22ASTELLAS PHARMA : to Present Fezolinetant 12-Week Findings from Phase 3 SKYLIGHT 2™ ..
PU
09/21ASTELLAS PHARMA : Science-based Exercise at Home with Fit-eNce HomeTM Pilot Sales Begins T..
PU
09/20ASTELLAS PHARMA : ' and Pfizer's XTANDI« (enzalutamide) Reduced Risk of Death by 34% in Me..
PU
09/20ASTELLAS PHARMA : ' and pfizer's xtandi (enzalutamide) reduced risk of death by 34% in men..
AQ
09/09ASTELLAS PHARMA : Updates “Contact for Potential Acquisition of ' R&D Programs&rdquo..
PU
09/02ASTELLAS PHARMA : Nitto, and M. Heart Partnering for ECG testing service
PU
09/01Astellas Provides Update on ASPIRO Clinical Trial of AT132 in Patients with X-linked My..
CI
08/31ASTELLAS PHARMA : Announces Personnel Changes
PU
08/30ASTELLAS PHARMA : Launches its Corporate Website's New Modalities~Approach for Cell..
PU
08/20SECTOR UPDATE : Health Care Stocks Mixed Premarket Friday
MT
08/20FIBROGEN : Receives $120 Million Milestone Payment With Approval of Evrenzo in Europe
MT
08/20ASTELLAS PHARMA : Receives European Commission Approval for First-in-Class EVRENZOTM (roxa..
PU
08/19ASTELLAS PHARMA : Receives European Commission Approval for First-in-Class EVRENZO™á..
AQ
08/19ASTELLAS PHARMA : Receives EC Approval for First-inClass EVRENZO (roxadustat) for Adult Pa..
PU
08/19Astellas Receives EC Approval for First-Inclass Evrenzo for Adult Patients with Symptom..
CI
08/18Nikkei snaps 4-day losing streak, but Delta worries persist
RE
08/17Japanese shares bounce back as defensive stocks gain
RE
08/17PRESS RELEASE : Basilea reports strong financial results for half-year 2021 with significa..
DJ
08/11FDA Rejects FibroGen's Roxadustat for Anemia of Chronic Kidney Disease
DJ
08/06ASTELLAS PHARMA : Reforms Research Organization
PU
08/05Modalis Announces Completion of a Research Collaboration on Angelman Syndrome and Regai..
CI
07/30ASTELLAS PHARMA : and Minovia Therapeutics Announce Strategic Collaboration for Novel Mito..
BU
07/30Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel Mitochondr..
CI
07/30Astellas Pharma Inc. Revises Earnings Guidance for the Full Year 2022
CI
07/30Astellas Pharma Inc. Reports Earnings Results for the First Quarter Ended June 30, 2021
CI
07/29ASTELLAS PHARMA : Financial Results (Q1/FY2021)
PU
07/29ASTELLAS PHARMA : Presentation Material for Information Meeting (Q1/FY2021)
PU
07/29ASTELLAS PHARMA : Supplementary Documents (Q1/FY2021)
PU
07/20The U.S. Food and Drug Administration Approves Astellas Pharma Inc.'s Supplemental New ..
CI
07/15Piers Morgan Joins Pharnext's Board of Directors
DJ
07/15Piers Morgan rejoint le Conseil d'Administration de Pharnext
DJ
07/13ExCellThera and Astellas Enters into a License for the Use of Molecule UM171 in the Fie..
CI
07/12Affinivax and Astellas Presents Safety and Immunogenicity Data from Phase 2 Study of AS..
CI
07/12ASTELLAS PHARMA : U.S. FDA Grants Regular Approval and Expands Indication for PADCEV (enfo..
AQ
07/11ASTELLAS PHARMA : U.S. FDA Grants Regular Approval and Expands Indication for PADCEV(enfor..
PU
07/09ASTELLAS PHARMA : U.S. FDA Grants Regular Approval and Expands Indication for PADCEV« (enf..
BU
06/29ASTELLAS PHARMA : Corporate Governance Report
PU
06/28ASTELLAS PHARMA : Receives Positive CHMP Opinion for EVRENZO (roxadustat) for Adult Patien..
PU
06/25FIBROGEN : Gets Positive Opinion From European Panel for Roxadustat in Patients With Anemi..
MT
06/25Astellas Receives Positive CHMP Opinion for EvrenzoÖ for Adult Patients with Symptomati..
CI
06/24PFIZER : First participant dosed in pfizer's pivotal phase 3 talapro-3 combination study o..
AQ
06/21Astellas Pharma to Incur Nearly $196 Million Impairment Loss From Termination of DNA Va..
MT
06/17ASTELLAS PHARMA : Notice Regarding Impairment Loss Following the Termination of DNA Vaccin..
PU
06/16ASTELLAS PHARMA : Transfers Five Legacy Products in Europe, Russia, CIS and Asia to Chepla..
PU
06/09ASTELLAS PHARMA : New Research Reflects Astellas' Commitment to Acute Myeloid Leukemia at ..
AQ
06/08Heavyweights pull Nikkei lower, Topix gains on drugmakers' boost
RE
06/07Nikkei falls as market heavyweights offset gains in drugmakers
RE
06/02ASTELLAS PHARMA : Reviewing capabilities for sustainable growth - Astellas Will Offer an E..
PU
06/02PRESS RELEASE : MorphoSys to Acquire Constellation -2-
DJ
05/31Japanese shares end lower on profit-booking, drugmakers limit losses
RE
05/30Japanese shares retreat from 3-week high; drugmakers limit losses
RE
05/26Japanese shares fall on profit-taking, pandemic worries
RE
05/20ASTELLAS PHARMA : and Seagen Announce Updated Results from Two Trials of PADCEV (enfortuma..
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ASTELLAS PHARMA INC.